2013
DOI: 10.3389/fpsyt.2013.00167
|View full text |Cite
|
Sign up to set email alerts
|

A Computational Hypothesis for Allostasis: Delineation of Substance Dependence, Conventional Therapies, and Alternative Treatments

Abstract: The allostatic theory of drug abuse describes the brain’s reward system alterations as substance misuse progresses. Neural adaptations arising from the reward system itself and from the antireward system provide the subject with functional stability, while affecting the person’s mood. We propose a computational hypothesis describing how a virtual subject’s drug consumption, cognitive substrate, and mood interface with reward and antireward systems. Reward system adaptations are assumed interrelated with the on… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 82 publications
0
6
0
Order By: Relevance
“…Other assumptions simplify parameter variation, an impact of environmental stressors, and ignore potential drug-seeking behaviors during withdrawal and craving. Although several complex models (Lamy, 2011; Levy, 2013) simultaneously include many aspects of measurable and unmeasurable human behavior, we started with a relatively simple model that was recently validated on data from animal experiments (Bobashev et al, 2015) and developed a representation of a specific substance use theory.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Other assumptions simplify parameter variation, an impact of environmental stressors, and ignore potential drug-seeking behaviors during withdrawal and craving. Although several complex models (Lamy, 2011; Levy, 2013) simultaneously include many aspects of measurable and unmeasurable human behavior, we started with a relatively simple model that was recently validated on data from animal experiments (Bobashev et al, 2015) and developed a representation of a specific substance use theory.…”
Section: Discussionmentioning
confidence: 99%
“…Comprehending a cascade of feedback loops between a variety of biologic, neurocognitive, behavioral, social, and environmental factors is one of the main challenges in substance use research. A few models exist that describe various feedback loops (Lamy et al, 2011; Levy et al, 2013; O’Reilly & Munakata, 2000). However, most of these models are quite complex, and their practical utility for prevention and treatment is low.…”
Section: Introductionmentioning
confidence: 99%
“…By changing the ratio of a-and b-process magnitudes, one can easily adjust the rate of development of allostasis and apparent tolerance. If more sophisticated modification is required, one could add a parallel tolerance compartment to create a feedback loop, similar to those in control system models of addiction in the literature (e.g., Ahmed & Koob, 2005;Amigó et al, 2008;Bobashev et al, 2017;Chou & D'Orsogna, 2022;Dumas & Pollack, 2008;Gårdmark et al, 1999;Levy et al, 2013;Newlin et al, 2012;Peper, 2009b;Porchet et al, 1988;Upton & Mould, 2014;Zou et al, 2020). Several types of functional tolerance, both competitive and non-competitive, could be added, including both pharmacokinetic tolerance (such as changes in metabolite production or transporter function) and pharmacodynamic tolerance (such as modifications to receptor functionality or changes to signal pathways) (Dumas & Pollack, 2008).…”
Section: Modifying the Modelmentioning
confidence: 99%
“…Converging data from addiction and BD studies suggest that these disorders involve similar allostatic processes, and allostasis can contribute to unify these disorders under a unitary perspective. In this context, the concepts of allostasis and AL provide both a pathophysiological model for the understanding of BD-addiction comorbidity and a new perspective for the development of novel therapeutic strategies for the treatment of comorbid patients ( 100 , 101 ).…”
Section: Clinical Implications and Future Perspectivesmentioning
confidence: 99%